Erika Reynoso graduated from California State University, Los Angeles in June 2005 with a B.S. in Microbiology. As an undergraduate, Erika spent time studying the antimicrobial peptide human defensin-5 (HD-5) in the small intestine. She also spent a summer at the National Institutes of Health where she was involved in the biochemical characterization of a novel drug which had the potential to function as an inhibitor of a signal transduction pathway involved in the progression of non-small cell lung cancer. Currently, she is working on her Ph.D. in the Harvard Immunology program under the advisement of Dr. Turley. She is interested in characterizing the roles of dendritic cells and lymph node stromal cells in the induction of T cell tolerance to intestinal antigens.
Erika is originally from California but she loves New England because of its seasons. She enjoys reading, knitting, shoe shopping, gardening, photography, walking, sight seeing, taking road trips, and eating fine dark chocolate with wine.